Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

31.1. Analysis.

31.1

Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 1 Pain (0‐100 mm VAS) change between baseline and 45 to 52 weeks post‐injection.